Hong Kong Stock Announcement Nuggets | China Resources Land's cumulative contract sales amount in the first 11 months was about 192.6 billion yuan, down 15.9% year on year

Important matters:

Fu Hong Han Lin (02696): The marketing registration application for Hans Xiang® combined chemotherapy for new adjuvant/adjuvant treatment for gastric cancer has been accepted by the State Drug Administration and included in priority review

Bishengyuan (00926) increased investment in ERX to maintain 3% shareholding to support innovative research and development of non-GLP-1 weight loss therapies

CSPC Group (01093): New indications for Doenyi® (irinotecan hydrochloride liposome injection) were approved for marketing

COSCO Marine Energy (01138) signed a shipbuilding contract to build an ethylene ship and 18 tankers at a total cost of 7.882 billion yuan

Nuochengjianhua (09969): Phase IIb clinical trial of obutinib to treat systemic lupus erythematosus achieved positive results and initiated phase III clinical trials

Delin Holdings (01709) deployed efficient mining hardware in selected overseas mines to continue to actively develop and expand institutional-level Bitcoin mining business

Chalk (02469) and Huatu signed a strategic cooperation agreement to consolidate their leading position in the industry

Operating performance:

R&F Real Estate (02777)'s total sales revenue for the first 11 months was about 12.7 billion yuan, up 24.63% year-on-year

Zhongan Online (06060)'s total insurance premium income for the first 11 months was about 32.904 billion yuan

The cumulative contract sales amount of Yuexiu Real Estate (00123) in the first 11 months was about 97.218 billion yuan

The cumulative contract sales amount of China Resources Land (01109) in the first 11 months was about 192.6 billion yuan, a year-on-year decrease of 15.9%